TY - JOUR
AU - 
TI - Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial
JO - Annals of Oncology
DO - 10.1093/annonc/mdw055
DA - 2016-05-01
UR - https://www.deepdyve.com/lp/unpaywall/observation-versus-late-reintroduction-of-letrozole-as-adjuvant-VUgLQQfAXi
DP - DeepDyve
ER -